Preclinical Development: Early Considerations for Different Molecule Types -Tina Rogers

preview_player
Показать описание
Watch & Listen to our Distinguished speaker Dr. Tina Rogers of Sinclair Research as she discusses: Preclinical Development: Early Considerations for Different Molecule Types at the PDDP Summit.

This talk was delivered at the Virtual Precision in Drug Discovery & Preclinical Summit on June 8th-9th , 2021 Via FLOOR.

#PCT #PrecisionEvents #vaccine #VirtualPDDP
#flattenthecurve #PDDP
#DrugDiscovery #preclinical #covid19
#coronavirus #HTS #drugdevelopment
#pharmaceuticals #biotechnology #cancer
#science #informatics #oncology
#cardio #alzheimers #discoveryoutsourcingservices
#hittolead #chemistry #biopharma
#pharma #biotech #Opioids
#pipeline #researchanddevelopement #genomics
#therapeutics #medicines #medicinalchemistry #innovation #summit #event #CNS #Therapeutics
Add on
  1. Precision Evolution Global
Рекомендации по теме
Preclinical Development: Early 0:27:06

Preclinical Development: Early Considerations for Different Molecule Types -Tina Rogers

Bootcamp Preclinical Toxicology: 0:18:57

Bootcamp Preclinical Toxicology: Pitfalls in Preclinical Development from the Regulatory Perspective

Key Considerations for 0:19:01

Key Considerations for the Pre-clinical Development of Therapeutic Innovations

The Role of 0:07:57

The Role of Preclinical Studies in Drug Development

Oligonucleotide therapeutic development: 0:25:00

Oligonucleotide therapeutic development: Pre-clinical and translational considerations

Preclinical Research and 0:44:12

Preclinical Research and Development considerations fro Nanomedicine

Preclinical Development of 1:11:25

Preclinical Development of Novel Therapeutics Targeting Aging Mechanisms (with Audio Descriptions)

Preclinical Development of 1:08:28

Preclinical Development of Novel Therapeutics Targeting Aging Mechanisms

iPSCs & 3D 0:56:07

iPSCs & 3D Culture Systems: Transforming Regenerative Medicine & Drug Discovery

Webinar — Strategic 0:55:26

Webinar — Strategic Considerations for a Successful CNS Clinical Development Pathway

Drug discovery and 0:07:22

Drug discovery and development process

PODCAST—Key Considerations as 0:14:47

PODCAST—Key Considerations as you Move from Discovery to Preclinical to Clinical

Webinar - Navigating 0:48:41

Webinar - Navigating the ABCs of Early Phase CNS Drug and Cannabinoid Development by Dr. Setnik

Webinar — Ethnobridging 0:48:21

Webinar — Ethnobridging in Phase I Clinical Trials

Development Considerations for 0:32:17

Development Considerations for Lipid-Based Formulation (LBF) from Preclinical Toxicology

Lost in translation: 0:21:58

Lost in translation: learning from preclinical data | Gerry Davies

Coping with Preclinical 0:47:06

Coping with Preclinical Toxicology Challenges

Considerations of using 0:04:33

Considerations of using preclinical data in a first-in-man trial

Drug Discovery and 0:07:50

Drug Discovery and Development - Overview | New Drug Discovery Procedure | Science Land

Keynote Presentation Molecular 0:46:36

Keynote Presentation Molecular Pharmacology Profiling the Precursor to Preclinical Development

ESCMID/ASM Conference 2022 1:47:53

ESCMID/ASM Conference 2022 Bootcamp 2 : Discovery and preclinical development challenges

Preclinical Drug Development 0:07:46

Preclinical Drug Development

Careers in Biotech 0:55:14

Careers in Biotech & Pharma: Exploring Approaches to Developing Pharmaceuticals

Moving from preclinical 2:00:06

Moving from preclinical to clinical-stage: Challenges & opportunities